Cite Filings / KPTI / 0000093751-22-000205
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Karyopharm Therapeutics Inc. · Filed 2022-02-11 · Acc 0000093751-22-000205

Documents 1

  • SC 13G/A Amended Statement of Ownership , KARYOPHARM_THERAPEUTICS_INC.txt

Around this filing

  • 2022-02-11 SC 13G/A Amended Statement of Ownership
  • 2022-02-11 SC 13G/A Amended Statement of Ownership
  • 2022-02-11 SC 13G/A Amended Statement of Ownership
  • 2022-02-09 4 EVP, CFO & Treasurer sold 3,947 shares at $9.86 ($38,925)
  • 2022-02-09 4 Director sold 13,471 shares at $9.86 ($132,851)
  • 2022-02-09 4 Chief Scientific Officer sold 13,471 shares at $9.86 ($132,851)
  • 2022-01-26 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RA Capital Management, L.P. 9.9%
  2. 2026-11-13 SCHEDULE 13G/A · Affinity Asset Advisors, LLC 6.5%
Loading KARYOPHARM_THERAPEUTICS_INC.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…